Scheinberg P, Cle DV, Kim JS, Nur E, et al. Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria. Am J Hematol 2024;99:1757-1767.
PMID: 38924124